Publication | Closed Access

A validated LC–MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: Application to a clinical pharmacokinetic study

Hematological MalignancyTherapeutic Drug MonitoringOncologyHealth SciencesAnti-leukemic Agent DasatinibMedicineHematologyHuman PlasmaPharmacotherapyAnti-cancer AgentValidated Lc–ms/ms AssayPharmacologyRadiation OncologyCancer ResearchDrug Analysis